A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch™ for Clinical Islet Transplantation

Clinical trial NCT03513939 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03513939
Sponsor: Sernova Biotherapeutics Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus

Start date: 2019-02-07
Primary completion: 2026-10-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.